| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 11 | 2025 | 674 | 1.720 |
Why?
|
| Hospitalization | 25 | 2026 | 1874 | 1.390 |
Why?
|
| Influenza Vaccines | 7 | 2024 | 481 | 1.360 |
Why?
|
| Intubation, Intratracheal | 10 | 2025 | 285 | 1.180 |
Why?
|
| Vaccination | 12 | 2026 | 1004 | 0.930 |
Why?
|
| Laryngoscopes | 5 | 2025 | 71 | 0.930 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2024 | 185 | 0.880 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2026 | 357 | 0.860 |
Why?
|
| Critical Illness | 8 | 2024 | 604 | 0.810 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2019 | 4 | 0.630 |
Why?
|
| Tracheal Neoplasms | 1 | 2019 | 20 | 0.620 |
Why?
|
| Bronchoscopy | 5 | 2019 | 177 | 0.610 |
Why?
|
| Pneumonia | 2 | 2022 | 334 | 0.600 |
Why?
|
| Laryngoscopy | 4 | 2025 | 157 | 0.590 |
Why?
|
| Esophageal Achalasia | 1 | 2019 | 44 | 0.590 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 240 | 0.500 |
Why?
|
| Pleurisy | 1 | 2015 | 6 | 0.480 |
Why?
|
| Respiration, Artificial | 4 | 2022 | 489 | 0.470 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2015 | 4 | 0.470 |
Why?
|
| Time | 1 | 2015 | 94 | 0.460 |
Why?
|
| Adult | 39 | 2026 | 30410 | 0.460 |
Why?
|
| Risk Assessment | 3 | 2015 | 3586 | 0.460 |
Why?
|
| Aged | 31 | 2026 | 20344 | 0.450 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 24 | 0.450 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2025 | 70 | 0.440 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2014 | 34 | 0.440 |
Why?
|
| Humans | 70 | 2026 | 126753 | 0.420 |
Why?
|
| Middle Aged | 32 | 2026 | 27697 | 0.410 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 171 | 0.410 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2019 | 220 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 2039 | 0.400 |
Why?
|
| Respiratory Syncytial Virus, Human | 3 | 2026 | 219 | 0.390 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2012 | 7 | 0.390 |
Why?
|
| Severity of Illness Index | 5 | 2026 | 2975 | 0.370 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 231 | 0.370 |
Why?
|
| Hypoxia | 2 | 2024 | 243 | 0.350 |
Why?
|
| United States | 20 | 2026 | 11310 | 0.350 |
Why?
|
| Heart Arrest | 3 | 2025 | 362 | 0.340 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 470 | 0.340 |
Why?
|
| Pneumonectomy | 1 | 2012 | 149 | 0.340 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2019 | 88 | 0.330 |
Why?
|
| Shock | 2 | 2022 | 96 | 0.330 |
Why?
|
| Noninvasive Ventilation | 2 | 2024 | 32 | 0.320 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 559 | 0.310 |
Why?
|
| Case-Control Studies | 8 | 2026 | 3314 | 0.300 |
Why?
|
| Female | 33 | 2026 | 68330 | 0.300 |
Why?
|
| Immunocompromised Host | 3 | 2022 | 302 | 0.290 |
Why?
|
| Male | 30 | 2026 | 62543 | 0.270 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 3 | 2024 | 122 | 0.270 |
Why?
|
| Aged, 80 and over | 9 | 2025 | 6668 | 0.250 |
Why?
|
| Seasons | 3 | 2024 | 309 | 0.250 |
Why?
|
| Influenza A virus | 2 | 2025 | 148 | 0.250 |
Why?
|
| Multimorbidity | 1 | 2026 | 25 | 0.240 |
Why?
|
| Hypothermia, Induced | 2 | 2017 | 164 | 0.240 |
Why?
|
| Legionnaires' Disease | 2 | 2017 | 8 | 0.240 |
Why?
|
| Oseltamivir | 1 | 2025 | 19 | 0.230 |
Why?
|
| Self Report | 2 | 2025 | 534 | 0.230 |
Why?
|
| Bias | 1 | 2024 | 134 | 0.210 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1861 | 0.210 |
Why?
|
| Polysomnography | 3 | 2019 | 147 | 0.210 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 92 | 0.200 |
Why?
|
| Hemoptysis | 2 | 2021 | 22 | 0.200 |
Why?
|
| Electronic Health Records | 3 | 2025 | 781 | 0.200 |
Why?
|
| Prospective Studies | 8 | 2025 | 6214 | 0.190 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2003 | 101 | 0.190 |
Why?
|
| Paclitaxel | 1 | 2003 | 128 | 0.190 |
Why?
|
| Respiratory Paralysis | 1 | 2001 | 6 | 0.180 |
Why?
|
| Pulmonary Atelectasis | 1 | 2001 | 13 | 0.180 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2021 | 9 | 0.180 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 214 | 0.180 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 39 | 0.180 |
Why?
|
| Fluid Therapy | 1 | 2022 | 145 | 0.180 |
Why?
|
| Immunization, Secondary | 1 | 2022 | 114 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2025 | 333 | 0.170 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 316 | 0.170 |
Why?
|
| Young Adult | 9 | 2026 | 9665 | 0.170 |
Why?
|
| Hypotension | 1 | 2022 | 182 | 0.170 |
Why?
|
| Aneurysm | 1 | 2021 | 70 | 0.170 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2001 | 124 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 278 | 0.160 |
Why?
|
| Adolescent | 9 | 2026 | 20002 | 0.160 |
Why?
|
| RNA, Messenger | 5 | 2023 | 2537 | 0.160 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2020 | 73 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2022 | 174 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2025 | 757 | 0.160 |
Why?
|
| Aneurysm, False | 1 | 2021 | 84 | 0.160 |
Why?
|
| Intensive Care Units | 3 | 2024 | 497 | 0.160 |
Why?
|
| Mediastinitis | 2 | 2017 | 16 | 0.150 |
Why?
|
| Azithromycin | 1 | 2019 | 43 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2021 | 354 | 0.150 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 105 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2003 | 443 | 0.150 |
Why?
|
| Cough | 1 | 2019 | 94 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 880 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2002 | 395 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2019 | 358 | 0.140 |
Why?
|
| Home Care Services | 1 | 2018 | 67 | 0.140 |
Why?
|
| Video Recording | 3 | 2025 | 200 | 0.140 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 30 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2003 | 1234 | 0.130 |
Why?
|
| Long-Term Care | 1 | 2017 | 68 | 0.130 |
Why?
|
| Fever | 1 | 2019 | 309 | 0.130 |
Why?
|
| Paramyxoviridae Infections | 1 | 2017 | 46 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 873 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 622 | 0.120 |
Why?
|
| Bacteremia | 1 | 2020 | 420 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2017 | 107 | 0.120 |
Why?
|
| Oxygen | 3 | 2024 | 541 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 143 | 0.120 |
Why?
|
| Sentinel Surveillance | 2 | 2025 | 22 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 2507 | 0.120 |
Why?
|
| Logistic Models | 2 | 2021 | 1779 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2015 | 79 | 0.110 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 249 | 0.110 |
Why?
|
| Legionella | 1 | 2014 | 9 | 0.110 |
Why?
|
| Hospital Mortality | 3 | 2025 | 1047 | 0.110 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 247 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 1184 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2017 | 413 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 167 | 0.100 |
Why?
|
| Lung | 3 | 2014 | 1516 | 0.100 |
Why?
|
| Vaccines, Combined | 2 | 2022 | 39 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 1493 | 0.090 |
Why?
|
| Influenza B virus | 2 | 2024 | 98 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2015 | 1207 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1364 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 541 | 0.090 |
Why?
|
| Trachea | 2 | 2023 | 204 | 0.090 |
Why?
|
| Retrospective Studies | 8 | 2020 | 17005 | 0.090 |
Why?
|
| Emergency Service, Hospital | 3 | 2024 | 1166 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 290 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 1479 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2289 | 0.080 |
Why?
|
| Prevalence | 3 | 2026 | 2591 | 0.080 |
Why?
|
| RNA | 2 | 2023 | 518 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 1236 | 0.070 |
Why?
|
| Prognosis | 2 | 2015 | 4772 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1195 | 0.070 |
Why?
|
| Sleep | 2 | 2019 | 352 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2225 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 5114 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2026 | 284 | 0.060 |
Why?
|
| Masks | 1 | 2024 | 37 | 0.050 |
Why?
|
| Risk Factors | 4 | 2026 | 10555 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2023 | 63 | 0.050 |
Why?
|
| Bronchial Diseases | 1 | 2003 | 11 | 0.050 |
Why?
|
| Platinum | 1 | 2003 | 13 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2006 | 226 | 0.050 |
Why?
|
| Time Factors | 2 | 2024 | 6134 | 0.050 |
Why?
|
| Mediastinoscopy | 1 | 2002 | 6 | 0.050 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2002 | 11 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 12546 | 0.050 |
Why?
|
| Positive-Pressure Respiration | 1 | 2022 | 83 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2003 | 1495 | 0.050 |
Why?
|
| Embolism, Paradoxical | 1 | 2001 | 3 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2022 | 30 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2003 | 1284 | 0.050 |
Why?
|
| Heart Septum | 1 | 2001 | 44 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2022 | 104 | 0.050 |
Why?
|
| Immunization | 1 | 2023 | 300 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 131 | 0.040 |
Why?
|
| Viral Load | 1 | 2023 | 398 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2003 | 171 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 730 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2023 | 510 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 130 | 0.040 |
Why?
|
| Demography | 1 | 2021 | 237 | 0.040 |
Why?
|
| Texas | 2 | 2021 | 3551 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 898 | 0.040 |
Why?
|
| Vancomycin Resistance | 1 | 2020 | 21 | 0.040 |
Why?
|
| Diaphragm | 1 | 2001 | 101 | 0.040 |
Why?
|
| Enterococcus | 1 | 2020 | 31 | 0.040 |
Why?
|
| Subclavian Artery | 1 | 2021 | 70 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2021 | 226 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2022 | 230 | 0.040 |
Why?
|
| Angiography | 1 | 2021 | 192 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2001 | 142 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 849 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1137 | 0.040 |
Why?
|
| Heart Atria | 1 | 2001 | 326 | 0.040 |
Why?
|
| Lung Transplantation | 1 | 2003 | 344 | 0.040 |
Why?
|
| Vancomycin | 1 | 2020 | 221 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2022 | 1584 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 774 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 541 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 1162 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2022 | 1194 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2001 | 253 | 0.030 |
Why?
|
| Tracheal Stenosis | 1 | 2017 | 31 | 0.030 |
Why?
|
| Cardiac Catheterization | 1 | 2001 | 629 | 0.030 |
Why?
|
| Legionella pneumophila | 1 | 2017 | 6 | 0.030 |
Why?
|
| Critical Care | 1 | 2002 | 668 | 0.030 |
Why?
|
| Patient Safety | 1 | 2021 | 434 | 0.030 |
Why?
|
| Metapneumovirus | 1 | 2017 | 47 | 0.030 |
Why?
|
| Length of Stay | 2 | 2017 | 1377 | 0.030 |
Why?
|
| Stents | 2 | 2017 | 769 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3662 | 0.030 |
Why?
|
| Drainage | 1 | 2017 | 250 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 172 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 667 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2109 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1131 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2017 | 377 | 0.030 |
Why?
|
| Incidence | 2 | 2017 | 3251 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1420 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2014 | 22 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 311 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 792 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2014 | 43 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 533 | 0.030 |
Why?
|
| Bronchi | 1 | 2014 | 102 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 314 | 0.030 |
Why?
|
| Animals | 1 | 2014 | 33051 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1398 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 531 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2003 | 3066 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4954 | 0.020 |
Why?
|
| Ohio | 1 | 2006 | 86 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2006 | 15 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 208 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2006 | 263 | 0.010 |
Why?
|
| Brain Diseases | 1 | 2006 | 283 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2006 | 211 | 0.010 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2003 | 49 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 280 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 2002 | 153 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 421 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2001 | 424 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 1259 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 649 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 1374 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 1220 | 0.010 |
Why?
|